Complete Wegovy Dose Schedule & Switching Guide
Understanding What Are The Doses Of Wegovy When Switching Medications
What are the doses of Wegovy becomes particularly important when transitioning from other GLP-1 receptor agonists like Mounjaro (tirzepatide) or Ozempic (semaglutide for diabetes). Wegovy follows a mandatory five-step dose escalation: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and finally 2.4mg as the maintenance dose from week 17 onwards. This structured approach minimises gastrointestinal side effects whilst allowing your body to adapt to the medication gradually. Unlike some competitors, you cannot skip doses or accelerate the escalation schedule, ensuring optimal tolerability throughout your treatment journey.
When switching from Mounjaro, many patients find Wegovy's dosing schedule more predictable and better tolerated. The Switch & Save programme at EverydayMeds provides seamless transition support, with our clinical team advising on approximate dose equivalents based on your current medication and tolerance levels. Our GPhC-registered prescribers (#9012878) assess your individual circumstances to determine whether you should restart at 0.25mg or begin at a higher equivalent dose. This personalised approach ensures continuity of treatment whilst potentially reducing your monthly medication costs significantly.
Wegovy Pricing Structure & Switch & Save Benefits
Understanding what are the doses of Wegovy includes knowing the investment required at each escalation stage. Single pen pricing starts with our 0.25mg starter dose at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the maintenance 2.4mg dose at £209.99. New customers use code FIRST40 at checkout to reach these competitive prices, whilst returning customers apply code DOSE25. These prices represent significant savings compared to traditional pharmacy channels, with potential monthly savings of £80-120 depending on your dose requirements.
Our bundle options provide additional convenience for patients planning their dose escalation journey. The Intro Trio bundle (0.25mg, 0.5mg & 1mg) costs £299.99, covering your first 12 weeks of treatment with Reliable Supply continuity. For patients established on maintenance dosing, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99, eliminating the need for monthly reordering. The Switch & Save programme ensures patients transitioning from other medications receive priority processing and enhanced clinical support throughout their conversion period.
Clinical Evidence Supporting Wegovy Dose Escalation Protocol
What are the doses of Wegovy is grounded in robust clinical evidence from the STEP trial programme. In clinical trials, patients taking Wegovy alongside diet and exercise achieved ~15% average weight loss at 68 weeks in STEP 1, with the structured dose escalation proving crucial for both efficacy and tolerability. The STEP 2 trial demonstrated ~9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 achieved ~16% with intensive behavioural therapy support.
The recent SELECT trial provided additional cardiovascular outcome data, showing a 20% reduction in major cardiovascular events (HR 0.80) in patients receiving Wegovy compared to placebo. These results, published by Wilding et al. in NEJM 2021, establish Wegovy as a prescription-only medicine with comprehensive evidence across multiple patient populations, supporting the current licensed dose escalation schedule approved by MHRA.
How Wegovy Works At Each Dose Level
Understanding what are the doses of Wegovy requires knowledge of the medication's mechanism of action as a GLP-1 receptor agonist. Semaglutide mimics the natural incretin hormone GLP-1, which your intestines release after eating to signal fullness to your brain. At lower doses (0.25mg-0.5mg), patients typically notice reduced appetite and earlier satiety during meals, whilst higher doses (1.7mg-2.4mg) provide more pronounced effects on food cravings and portion control. The gradual dose escalation allows your GLP-1 receptors to adapt progressively, minimising common side effects like nausea, vomiting, and gastrointestinal discomfort. This mechanism works centrally in the brain's appetite control centres and peripherally by slowing gastric emptying, creating a comprehensive approach to weight management that extends beyond simple appetite suppression.
EverydayMeds Ordering Process & Clinical Assessment
Accessing Wegovy through our Switch & Save programme begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our MHRA-licensed prescribers review your application within 3 working days (or 24 hours with express service), determining both your eligibility for Wegovy and the appropriate starting dose based on any previous GLP-1 experience. Once approved, your medication ships via next-day delivery using temperature-controlled cold-chain logistics, ensuring the semaglutide remains stable throughout transit. Each shipment includes detailed administration instructions, dose escalation scheduling, and 24/7 clinical support contact details for any questions during your treatment. Our GPhC-registered pharmacy (#9012878) maintains comprehensive medication records, automatically scheduling your next dose escalation and providing proactive refill reminders to prevent treatment interruptions.
Storage Requirements & Practical Considerations For Each Wegovy Dose
What are the doses of Wegovy also encompasses proper storage and handling requirements that remain consistent across all dose strengths. Each FlexTouch pen must be stored in the refrigerator at 2-8°C before first use, with each pen providing four weekly doses regardless of the mg strength. Once removed from refrigeration, Wegovy pens can be stored at room temperature (below 30°C) for up to 6 weeks, providing superior travel flexibility compared to Mounjaro's 21-day room temperature limit. The pen design includes a dose counter window showing remaining doses, and each pen should be discarded 56 days after first use, even if doses remain. Patients should rotate injection sites weekly between the thigh, upper arm, and abdomen, and never share pens due to infection risk.
Dose Conversion Guidance When Switching From Other GLP-1 Medications
What are the doses of Wegovy becomes complex when transitioning from Mounjaro or other GLP-1 therapies, as direct dose equivalency tables don't exist due to different mechanisms of action. Patients switching from Ozempic (semaglutide for diabetes) may continue at their current dose if within Wegovy's range, though clinical reassessment ensures the dose remains appropriate for weight management versus glycemic control. Those transitioning from Mounjaro typically restart Wegovy's escalation schedule at 0.25mg or 0.5mg, depending on their previous tolerance and current tirzepatide dose strength.
Our Switch & Save programme provides personalised conversion guidance through one-to-one prescriber consultations, ensuring no treatment gaps during the transition period. The clinical team considers factors including previous side effect experience, weight loss velocity, and individual tolerance patterns when recommending your optimal Wegovy starting dose. This careful approach minimises the risk of treatment discontinuation whilst maximising the potential benefits of switching medications, with ongoing monitoring throughout your first 12 weeks on the new dosing protocol.
Complete Your Switch & Save Today
Understanding what are the doses of Wegovy empowers you to make informed decisions about switching from your current weight management medication to a potentially more suitable and cost-effective option. Our comprehensive dose range, competitive pricing structure, and clinical expertise ensure your transition proceeds smoothly with optimal outcomes. New customers should use code FIRST40 at checkout, whilst returning patients apply code DOSE25 to access our competitive pricing across all dose strengths. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today, with next-day delivery available once approved by our prescribing team. Remember that Wegovy is a prescription-only medicine requiring clinical assessment and should always be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
